Skip to main content

JANE STREET GROUP, LLC

Position in REPL — Replimune Group, Inc.

CIK 1595888 NEW YORK, NY

Position in REPL

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$3,275,308
-$2,404,378 QoQ
Shares Held
428,145
-26.7% QoQ
Ownership
0.510%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Derivatives in REPL

reported options exposure · as of Mar 31, 2026
CallValue
$1,518,525
CallShares
198,500
PutValue
$211,140
PutShares
27,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. REPL ranks #60 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REPL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,518,525 198,500
2026-03-31 $3,275,308 428,145
2026-03-31 $211,140 27,600
2025-12-31 $550,152 56,600
2025-12-31 $1,989,684 204,700
2025-12-31 $5,679,686 584,330
2025-09-30 $1,427,533 340,700
2025-09-30 $351,960 84,000
2025-09-30 $2,448,111 584,275
2025-06-30 $224,818 24,200
2025-06-30 $3,128,872 336,800
2025-06-30 $809,576 87,145
2025-03-31 $2,582,725 264,895
2024-12-31 $3,830,234 316,287
2024-09-30 $2,874,236 262,248
2024-06-30 $4,826,934 536,326
2024-03-31 $1,289,371 157,818
2023-12-31 $2,052,804 243,512
2023-06-30 $1,870,695 80,564
2023-03-31 $285,403 16,161
2022-12-31 $1,281,963 47,131